Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Filings indexed 969 across all filing types
Latest filing 2021-08-30 Board/Management Inform…
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated August 24, 2021, reporting the appointment of Wendy Levine as a director of Apyx Medical Corporation. The key section is Item 5.02, which specifically addresses the departure and election of directors or certain officers. The content focuses on board changes, including biographical details and compensation references. There is no financial data or report attached, and the document is not an earnings release, annual report, or other financial filing. The primary subject is a management/board change announcement. Therefore, the appropriate classification is Board/Management Information (MANG). The document length and detail support a confident classification.
2021-08-30 English
COWEN FINANCIAL PRODUCTS LLC
Major Shareholding Notification
2021-08-26 English
S-8
Share Issue/Capital Change Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock option plans. It includes details about the securities to be registered, the plan under which they are offered, and legal and indemnification information. It references incorporation of other filings like 10-K and 10-Q but is itself a registration statement for securities issuance under a share incentive plan. This type of filing is related to capital raising or share issuance activities but is not a financial report, earnings release, or management discussion. Therefore, it fits best under the category of Share Issue/Capital Change (SHA). The document length and content confirm it is the registration statement itself, not just an announcement or a certification, so it is not RPA or RNS. Confidence is high due to clear identification of Form S-8 and registration of shares under a share incentive plan.
2021-08-18 English
10-Q
Interim / Quarterly Report Q2 2021
2021-08-12 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 12, 2021, reporting the results of operations for the first fiscal quarter ended June 30, 2021. It references an attached earnings press release (Exhibit 99.1) that contains the financial results. The text explicitly states it is a current report and includes a press release on earnings results, which aligns with an Earnings Release. The document length is 3375 characters, which is relatively short but contains the actual earnings announcement rather than just a notice of report publication. Therefore, this is classified as an Earnings Release (ER).
2021-08-12 English
FORM 4
Director's Dealing
2021-08-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.